Patent · US Active

NLRP3 modulators

US12187706B2 · kind B2 · utility

0Cited by

0References

18Claims

0Family size

Assignee

Innate Tumor Immunity, Inc. · US

Inventors

Daniel O'Malley · New Hope, US
Ashvinikumar V. Gavai · Princeton Junction, US
Derek J. Norris · Pennington, US
Hua Gong · San Diego, US
Yong Zhang · Princeton, US
Patrice Gill · Fort Lee, US
Christine M. Tarby · Lawrenceville, US
Matthias Broekema · New Hope, US
Scott Hunter Watterson · Pennington, US

Key dates

Filing date	Jan 13, 2020
Grant date	Jan 7, 2025
Priority date	—
Expiry date	Dec 22, 2041

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D498/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention provides compounds of Formula (I): Formula (I) wherein all of the variables are as defined herein. These compounds are modulators of NLRP3, which may be used as medicaments for the treatment of proliferative disorders, such as cancer in a subject (e.g., a human).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.